论文部分内容阅读
慢性乙型肝炎感染是至今仍然困扰全球的一个健康问题。随着抗乙肝病毒药物的迅速发展,开展抗乙肝药物经济学评价以研究药物治疗方案的成本与效果及其关系是药物经济学评价研究的重要内容。本文通过检索PubMed、Web of Science等英文数据库近5年内公开发表关于乙肝防治方案药物经济学评价文献,对文献研究内容、研究结果进行系统述评。本文通过对相关文献的分析研究来简要介绍乙肝防治方案的药物经济学评价的方法和近期研究结果。
Chronic hepatitis B infection is a health problem that continues to plague the world to this day. With the rapid development of anti-hepatitis B virus drugs, the cost-effectiveness of anti-hepatitis B drug evaluation in order to study drug treatment programs and their relationship is an important part of the evaluation of drug economics. This article reviews PubMed, Web of Science and other English databases published in the past five years on the prevention and treatment of hepatitis B drug economics literature evaluation, literature review of the contents of the research results. This article through the relevant literature analysis to briefly introduce the prevention and treatment of hepatitis B drug economics evaluation methods and recent research results.